MAPT and hereditary pheochromocytoma-paraganglioma: In that study, a positive correlation between MAPT expression and survival in glioma, breast cancer, kidney clear cell carcinoma, lung adenocarcinoma, and pheochromocytoma/paraganglioma was described.